Background: Alzheimer's disease (AD) is a progressive neuropsychiatric disorder that causes
INTRODUCTION
Alzheimer's disease (AD) is a progressive neuropsychiatric disorder characterized by formation of senile plaques following neurofibrillary tangles which cause neuronal degeneration and synaptic loss. These senile plaques are formed in brain regions such as the entorhinal cortex, basal forebrain, hippocampus, and amygdale which can impair learning and memory functions [1] . The brains of AD also exhibit a number of pathological abnormalities, including significant loss of synapses, reactive gliosis and flaring up of the inflammatory process [2] .
Recent studies have indicated that neuroinflammation contributes to the pathogenesis of AD. It was suggested that neuroinflammation plays a crucial role in deposition of cerebral amyloid [3] . It has been shown that inflammatory cytokines such as interleukin (IL)-1β, IL-6, tumor necrosis factor-α (TNF-α) or transforming growth factor-β (TGF-β) can augment APP expression and Aβ formation [4] . Moreover, it was reported that cytokines are able to upregulate the transcription of β-secretase mRNA, protein and enzymatic activity. β-secretase is a key rate-limiting enzyme that initiates Aβ formation [5] . Also, the inflammatory mediators frequently encountered in AD were suggested to stimulate the underlying key events of the inflammatory cascade leading to increased Aβ production with activation of the microglial cells [6] .
It was reported that intraperitoneal injection of lipopolysaccharide (LPS) induces cognitive impairment in mice [7] . However, the mechanisms underlying LPS induced cognitive impairment are not yet fully understood. To investigate the impact of systemic inflammation on memory impairment and its role in cortical amyloid formation and deposition, LPS was an ideal agent to induce systemic inflammation and cognitive impairment and to investigate the effect of different drugs on AD [8] .
Sitagliptin is one of dipeptidyl dipeptidase-4 (DPP-4) inhibitors that are used for treatment of type II diabetes mellitus. They act by increasing certain hormones that stimulate the pancreas to produce more insulin and inhibit hepatic gluconeogenesis [9] . Sitagliptin was reported to possess pleiotropic antioxidant and antiinflammatory properties which may have beneficial effects on various body tissues [10] .
Moreover, sitagliptin was proven to have potent antifibrotic effects, possibly through its action on TGF-β1 which is the primary cytokine responsible for induction of the inflammatory cascade in different body organs [11] . Taken together, these properties may make sitagliptin to be a promising agent for amelioration of LPS-induced AD.
Calcipotriol is a synthetic derivative of calcitriol (Vitamin D) which is widely used for treatment of psoriasis and alopecia areata [12] . Vitamin D analogues such as calcipotriol were proven to have potent antioxidant and anti-inflammatory properties that may provide protection to various body tissues against oxidative stress and inflammation [13] . Also, calcipotriol was reported to protect from inflammation through antagonizing TGF-β1 signaling via vitamin D receptor/Smad3 genomic crosstalk. This blocks Smad residency on chromatin and inhibits acetylation of histone H 3 leading to suppression of gene expression of the pro-inflammatory cytokines [14] . The present study was undertaken to evaluate the ability of sitagliptin and/or calcipotriol to attenuate LPSinduced AD in mice and to elucidate their possible mechanisms of action. 
Materials and Methods

Drugs and chemicals
Experimental animals
In this study, we used sixty male Balb/c mice weighing about 18-25 grams. They were allowed to acclimatize for two weeks before starting the experiment. The animals were kept in a special room at a constant temperature of 23 ± 3 ˚C with relative humidity of 60 ± 10%, exposed to 12h 
Animals grouping:
Mice were randomized into six equal groups (10 mice/group) as follows:
Group (1) 
Behavioral tests (Novel object recognition task)
A novel object recognition task was carried out as described by Gomes et al. [17] . The task was 
Assessment of tissue oxidative stress parameters
Tissue catalase (CAT) was determined according to Sinha method [18] . Tissue superoxide dismutase (SOD) was assessed according to Marklund and Marklund [19] . Tissue thiobarbituric acid derivatives (TBARS) were determined using ELISA kits supplied by Cell Biolabs, Inc., San Diego, USA according to the manufacturer's instructions.
Assessment of tissue tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6) and transforming growth factor beta 1 (TGF-β1)
Tissue TNF-α was determined by using TNF-α Institute of Health, USA [21] .
Electron microscopic examination
The specimens of the hippocampus were fixed in 4% gluteraldehyde in 0.1 M cocodylate buffer (pH 7.4). Then, they were kept in gluteraldehyde solution for 24-48 hrs at 4°C. Then, they were cut into small pieces and washed with distilled water then fixed in 1% osmium tetraoxide with 15 mg/ml of potassium ferrocyanide for 1-2 hr at 4°C. Then, the specimens were cut using an utlramicrotome (JEOL-JUM-7) and stained with uranyl acetate and lead. Finally, the specimens were examined and photographed using a JEOL, JEM 1010 electron microscope (Jeol Ltd, Tokyo, Japan) [22] .
Statistical analysis
The statistical analysis of the results was performed using Graph Pad Prism version 5.
Multiple comparisons were performed using multiple measures analysis of variance (ANOVA)
followed by Tukey's multiple comparison test.
Data were presented as mean ± standard error of mean (SEM). Differences between the means of the different groups were considered significant at a level of p-value less than 0.05.
Results
Effect of different treatments on the novel object recognition task
Administration of LPS induced significant decrease in the recognition index compared to the control group. Administration of CMC prior to LPS injection induced non-significant effect on the recognition index compared to LPS group.
Administration of sitagliptin and/or calcipotriol prior to LPS injection induced significant increase in the recognition index compared to LPS group. This increase was significant in sitagliptin/calcipotriol combination group compared to the use of each of these drugs alone (Fig. 1) . 
Effect of different treatments on tissue oxidative stress parameters
Effect of different treatments on tissue TNF-α, IL-6 and TGF-β1
Administration 
Effect of different treatments on the histopathological, immunohistochemical and electron microscopic picture
Administration of LPS induced marked disorganization and degeneration of the pyramidal cells ( Fig. 2b ) with significant increase in tissue caspase 3 expression (Fig. 3b) and NF-κB (P 65) immunostaining (Fig. 4) compared to the control group. These changes were associated with significant decrease in the size of the nuclei of the pyramidal cells with marked vacuolation of the mitochondria and damage of cristae compared to the control group (Fig. 5b) . These changes were ameliorated with administration of sitagliptin and/or calcipotriol with restoration of the normal size and arrangement of the pyramidal cells (Fig.   2d, 2e ) with significant decrease in tissue caspase 3 expression (Fig. 3d,e) and NF-κB (P 65) immunostaining (Fig. 4) compared to the control group. These changes were associated with restoration of the normal size of the nuclei of the pyramidal cells with apparently normal mitochondria compared to the control group (Fig.   5d,e) . These changes were significant in sitagliptin/calcipotriol combination group compared to the use of each of these drugs alone (Fig. 2f, 3f, 4, 5f ). Administration of CMC prior to LPS injection induced non-significant effect on the histopathological, immunohistochemical and electron microscopic picture compared to LPS group (Fig. 2c, 3c, 4 , 5c).
. 
Discussion
Alzheimer's disease is one of degenerative brain disorders that markedly affects the patient's perception, memory, judgement and cognition [2] .
The exact mechanisms underlying this disorder are
still not yet fully understood but accumulating data suggest that neuroinflammation, oxidative stress and apoptosis may play a crucial role in this disorder [23] . This was in the same line with the results of the present study where LPS injection induced significant deterioration of the recognition index associated with significant increase in the proinflammatory cytokines, induction of oxidative stress and increased caspase 3 expression.
Oxidative stress was proven to play an important role in the pathogenesis of AD [24] . Increased production of reactive oxygen species and marked impairment of the activities of the antioxidant enzymes are prominent features of AD [25] . This was in agreement with the results of the present study where LPS induced significant decrease in the activities of tissue CAT and SOD with significant increase in tissue TBARS compared to the control group. These changes were ameliorated in the present study by administration of sitagliptin which was proven to have strong antioxidant and free radical scavenging activities [10] . Also, calcipotriol in the present study was able to restore the activities of the antioxidant enzymes and decrease the level of TBARS. Vitamin D analogues, including calcipotriol, have strong antioxidant properties which may be attributed to decreased production of reactive oxygen species and restoration of the protective mechanisms that protect the body against oxidative stress [12] .
Neuroinflammation was considered as the cornerstone in the pathophysiology of AD [26] .
NF-κB is a protein complex that controls DNA transcription, production of the proinflammatory cytokines and cell survival [10] . Freudlsperger et al. [27] reported that the cross-talk that exists between NF-κB and TGF-β1 signaling pathways is the triggering event that induces the production of the proinflammatory cytokines such as TNF-α and IL-6 which may have potential effects on memory and cognition. This was in the same line with the results of the present study where LPS administration induced significant increase in the expression of NF-κB, TGF-β1, TNF-α and IL-6 associated with significant histopathological changes compared to the control group.
In the present study, sitagliptin was able to decrease the levels of NF-κB, TGF-β1 and the proinflammatory cytokines compared to LPS group which was attributed to the fact that sitagliptin has potent anti-inflammatory effects on both the nuclear and cytoplasmic levels [28] .
Moreover, sitagliptin was reported to increase glucagon-like peptide 1 (GLP-1) which in turn inhibits the expression of both NF-κB and TGF-β1 at the nuclear level [29] . Also, calcipotriol in our study exerted potent anti-inflammatory effects, possibly due to the hypothesis that calcipotriol blocks smad residency on the chromatin and inhibits acetylation of histones leading to marked suppression of gene expression of the proinflammatory cytokines [16] .
Recent studies suggest that there is a strong relationship between induction of apoptosis and the increased liability to AD [30] . Dickson [31] reported that selective loss of the neurons in neurodegenerative disorders such as AD may be due to activation of cysteine aspartyl proteases such as caspase 3 which initiates apoptosis. In AD, both the extracellular and the intracellular amyloid proteins may activate caspases which in turn lead to cleavage of the intracellular proteins which strongly correlates with dementia [32] . This was in accordance with the results of the present study where LPS administration induced significant increase in caspase 3 expression compared to the control group. Sitagliptin in our study was able to decrease caspase 3 expression, possibly due to the effect of GLP-1 on PI3K/Akt signaling pathway which significantly affects the pathways of apoptosis in which caspase 3 is directly involved [33] . Also, calcipotriol in the present study ameliorated caspase 3 expression compared to LPS group. This may be due to the inhibitory effect of calcipotriol on TGF-β/Smad3 signaling pathway which is considered as one of the main regulators of apoptosis [34] . 
Conclusion
Sitagliptin/calcipotriol combination had a better effect on LPS-induced AD than the use of each of these drugs alone. This may be attributed to the antioxidant and the anti-inflammatory properties of both drugs together with their ability to affect apoptosis and restore the behavioral tests to the normal levels. This combination might represent a new therapeutic modality for amelioration of AD.
